Frequency 1x 4x 6x 12x 18x 24x 36x 48x 60x

Tabloid 6,680 6,520 6,380 6,140 5,930 5,760 5,500 5,400 5,300

2/3 Tabloid 5,910 5,670 5,470 5,140 4,950 4,750 4,570 4,420 4,200

1/2 Tabloid 4,890 4,800 4,610 4,510 4,310 4,160 3,980 3,900 3,750

1/3 Tabloid 3,350 3,230 3,080 3,020 2,960 2,930 2,840 2,740 2,580

1/4 Tabloid 3,160 3,030 2,930 2,820 2,620 2,560 2,400 2,330 2,230

Standard 5,250 5,140 5,020 4,710 4,570 4,360 4,160 4,000 3,920

2/3 Standard 3,350 3,230 3,080 3,020 2,960 2,930 2,840 2,740 2,580

1/2 Standard 2,890 2,800 2,680 2,590 2,480 2,420 2,340 2,270 2,160

1/3 Standard 2,270 2,200 2,090 1,830 1,780 1,670 1,610 1,530 1,480

1/4 Standard 1,660 1,580 1,530 1,450 1,390 1,330 1,270 1,240 1,190

Advertising Rates Commission: 15% to recognized agencies Inserts: Consult Advertising Director

4-color 1,400

2nd color matched from

process700

5th color or Pantone 900

Color

Ads produced with combinations of process inks (cyan, magenta, yellow, and black) use color most economically. Many Pantone (PMS) specified colors can often be approximated using process inks. CAP TODAY can help you plan the most efficient use of your color. Call Keith Eilers, 847-832-7528, for specific information. Circulation Frequency: Monthly Mailing: Periodical Class

Publisher/Sales Office Bob McGonnagle 325 Waukegan Road, Northfield, IL 60093 Phone: 847-832-7476; Fax: 847-832-8153 bmcgonn@cap.org

Production Keith Eilers, Managing Periodicals Editor 325 Waukegan Road, Northfield, IL 60093 Phone: 847-832-7528; Fax: 847-832-8528 keilers@cap.org

Jane Ure, Production Editor 325 Waukegan Road, Northfield, IL 60093 Phone: 847-832-7980; Fax: 847-832-8980 jure@cap.org

Advertising Directors East: Hally Birnbaum Mount Kisco, NY Phone: 914-218-1943; Fax: 847-832-8153 captodayeast@gmail.com

Midwest: Lori Prochaska Omaha, NE Phone: 402-290-7670; Fax: 847-832-8153 captodaycentral@cox.net

West: Diana Kelker Sacramento, CA Phone: 847-832-7749; Fax: 847-832-8749 dkelker@cap.org

Classified KERH Group, PO Box 207 Parker Ford, PA 19457 Phone: 888-489-1555 sales@kerhgroup.com

2019 RATE CARD

Every month CAP TODAY brings essential news to all keydecision-makers responsible for clinical laboratory purchases.This news includes advances in tests and equipment, trends in management and clinical operation, regulatory changes, and fi nance, plus news about the laboratory improvement programs of the College of American Pathologists.

Independent research studies show that CAP TODAY is #1in total ad exposures for the marketplace. Kantar Media Healthcare Research has

completed new studies on pathologists, clinical lab directors, lab managers and administrators, section managers and

supervisors, and total hospital purchasing infl uence. In 2018, CAP TODAY carried more advertising than any other book in the fi eld.

Essential monthly reporting on the clinical laboratory for lab managersand administrators, physicians, lab directors, and supervisory technologists.

Distribution

Readers* All key decision-makers, no excess

Pathologists and Laboratory Directors 17,000Laboratory Managers and Laboratory Administrators 5,000Chief Techs; Section Managers/Supervisors of Chemistry, Hematology, Microbiology, Immunology, Blood Bank, Cytology, or Histotechnology

22,000

TOTAL 44,000* This listing is specially grouped for convenience. See the BPA Publisher’s Statement for detailed circulation data.

Proven ResearchCAP TODAY offers the most thorough research in the fi eld. This allows advertisers to understand exactly how CAP TODAY delivers messages to the various professional titles and personnel in the circulation and serves to explain the laboratory market.Ask for copies or, better, presentations of studies on:1. Pathologist readership2. Readership by section managers and supervisors—often the backbone of your lab contacts and relationships3. Portrait of the clinical laboratory—purchasing and personnel data and readership by lab directors and lab administrators4. Purchasing infl uence—hospital executives tell us how their institutions acquire a range of lab products and services

Combined Frequency DiscountsInsertions in CAP TODAY and the Archives of Pathology & Laboratory Medicine combine to determine the earned rate in each publication. Call your representative for details.

Digital AdvertisingPrint advertisers receive value-added online ads. See our digital edition at www.captodayonline.com/mag In addition, CAP TODAY advertisers have exclusive digital advertising opportunities available. Please see separate CAP TODAY 2019 Digital offerings.exclusive digital advertising opportunities available.

Archives of Pathology

exclusive digital advertising opportunities available.

Special Section—Updated CAP, IASLC, and AMP Molecular Lung Cancer Testing Guideline; Updates From the 2016 Molecular

Cytopathology Meeting (Napoli, Italy), Part I

March 2018

Anaplastic Lymphoma Kinase Gene Rearrangement by Fluorescence In Situ

Hybridization in Non-Small Cell Lung Cancer on Direct Smears

Special Section—Updated CAP, IASLC, and AMP Molecular Lung Cancer Testing Guideline; Updates From the 2016 Molecular

Cytopathology Meeting (Napoli, Italy), Part I

March 2018

Anaplastic Lymphoma Kinase Gene Rearrangement by Fluorescence In Situ

Hybridization in Non-Small Cell Lung Cancer on Direct Smears

AD-MARK In 2019, CAP TODAY will test all ads in the February, June, and November issues. This service provides direct feedback from readers as to how an ad is received. Companies can track how an ad stacks up to others in the same product category, evaluate the half-life of an ad that has been running, and perform valuable benchmarking for new campaigns. Ask your representative for details.

◆◆◆ ReadEx Red Sticker Study October 2019 issue. The Red Sticker Study examines multiple facets of readers’ attitudes to ads—includes verbatim com-ments and measures of attention, appeal, and reading.List rental CAP TODAY makes its list available to advertisers at nominal rates. Ask your representative for details.Merchandising CAP TODAY can provide assistance to advertisers throughcustomized research projects and sales support efforts.

Reprints CAP TODAY reprints make valuable sales aids for the fi eld. Contact Production Editor Jane Ure at 847-832-7980 or jure@cap.orgIndependent syndicated media research on readership and ad placement. CAP TODAY participates in and can share results from independent media research on readership and ad placement in the clinical laboratory marketplace. Such media research is often the best aid in planning the most effective ad schedule. Ad placement and spending data for the market help establish essential metrics.Digital extras All advertisements in CAP TODAY are mirrored each month in the digital edition, at www.captodayonline.com/mag. Please provide your advertising director preferred target URL.

Services to advertisers

BD Diagnostics FILE— NEW AUGUST 2018 page 3

Automated workflow and decision-making

Informed staffing and workload management

On-demand analytics and remote access

• Rules engine streamlines workflow management

• Flags clinically significant results for review

• Drives informed standardization of lab testing practices

• Remote image reading allows anywhere, anytime access for any number of users

• Intuitive interface enables customizable dashboards and worklists

• Easy workload allocation focuses staff on key activities, impacting productivity and turnaround time

• Remote access enables consults as needed, potentially impacting turnaround time

• Comprehensive analytics drive laboratory efficiency and lean workflows

• Designed to support strong data security and privacy controls

Discover how BD Kiestra™ solutions and the BD Synapsys™ microbiology informatics solution combine to transform microbiology and improve laboratory outcomes. Learn more at bd.com/synapsys.© 2018 BD. BD, the BD Logo and all other trademarks are property of Becton, Dickinson and Company. BD, 7 Loveton Circle, Sparks, MD 21152-0999 USA Tel: 1.800.638.8663 bd.com

Connecting, integrating and empowering BD Kiestra™ Solutions to transform microbiology and improve laboratory outcomes.

The BD Synapsys™ informatics solution helps elevate laboratory automation performance through a secure and scalable integrated informatics platform.

BD Kiestra™ Solutions empowered by BD Synapsys™ Microbiology Informatics

22 in Bleed21.75 in Trim

14.1

25 in

Ble

ed13

.875

in T

rim

BD Diagnostics FILE— NEW AUGUST 2018 page 2 0818_TABs-Agena-Denka-12.indd 2 8/1/18 11:38 AM BD Diagnostics FILE— NEW AUGUST 2018 page 3

Automated workflow and decision-making

Informed staffing and workload management

On-demand analytics and remote access

• Rules engine streamlines workflow management

• Flags clinically significant results for review

• Drives informed standardization of lab testing practices

• Remote image reading allows anywhere, anytime access for any number of users

• Intuitive interface enables customizable dashboards and worklists

• Easy workload allocation focuses staff on key activities, impacting productivity and turnaround time

• Remote access enables consults as needed, potentially impacting turnaround time

• Comprehensive analytics drive laboratory efficiency and lean workflows

• Designed to support strong data security and privacy controls

Discover how BD Kiestra™ solutions and the BD Synapsys™ microbiology informatics solution combine to transform microbiology and improve laboratory outcomes. Learn more at bd.com/synapsys.© 2018 BD. BD, the BD Logo and all other trademarks are property of Becton, Dickinson and Company. BD, 7 Loveton Circle, Sparks, MD 21152-0999 USA Tel: 1.800.638.8663 bd.com

Connecting, integrating and empowering BD Kiestra™ Solutions to transform microbiology and improve laboratory outcomes.

The BD Synapsys™ informatics solution helps elevate laboratory automation performance through a secure and scalable integrated informatics platform.

BD Kiestra™ Solutions empowered by BD Synapsys™ Microbiology Informatics

22 in Bleed21.75 in Trim

14.1

25 in

Ble

ed13

.875

in T

rim

BD Diagnostics FILE— NEW AUGUST 2018 page 2 0818_TABs-Agena-Denka-12.indd 3 8/1/18 11:38 AM

PATHOLOGY ◆ LABORATORYMEDICINE ◆ LABORATORYMANAGEMENT JANUARY 2018

Vo

l. 32, N

o. 1

Mo

vin

g?

Fax

a c

opy

of th

e be

low

addr

ess

with

cor

rect

ions

to C

AP

TO

DAY

: 847

-832

-815

3.

Jenn

ifer

Altm

an

Clin Lab 2.0: Add value, make patients better

Anne Paxton

It was baseball’s Yogi Berra who said, with the

unique slant that was his hallmark, “In theory there

is no difference between theory and practice. In

practice, there is.” More vividly, boxer Mike Tyson

once summed up the same reality when asked to

comment on an opponent’s strategy

in an upcoming match: “Everybody

has a plan—until they get hit.”

Laboratories may not have to fear

such a sudden and traumatic hour of

reckoning. But as new payment mod-

els change volume-based health care

to value-based health care, these sports

lessons are relevant to the laboratory

industry’s strategic planning. If add-

ing value, in theory, is becoming es-

sential to laboratories’ survival, what

does that mean they should do, in

practical terms?

To explore the next era for health

care and what it means for labs, CEOs

and directors from Geisinger Health,

Henry Ford Health System, North-

well Health Laboratories, Kaiser Per-

manente North Laboratories, and

TriCore Reference Laboratories began

meeting in March 2016 as “Project Santa Fe.” They

see their concept of Clinical Laboratory 2.0, empha-

sizing demonstration of how the laboratory adds

value to patient care, as a critical clinical and busi-

ness model for re-engineering laboratories’ role in

the health care system.

“The value discussion has been underway for

some years,” says founding member James Craw-

ford, MD, PhD, senior vice president of laboratory

services at Northwell Health in the greater New York

metropolitan area. “Project Santa Fe was founded to

bring together like-minded

Genotype-guided dosing of warfarin: GIFT wrap-up

Elizabeth Silverman

In an ideal world, clinical research

data would be applied with immedi-

ate and beneficial effect to clinical

practice, especially when the data

come from a well-controlled, well-run

trial that meets the gold standard of

being large, randomized, and blind-

ed. However, as the Sept. 26 publica-

tion of the Genetic Informatics Trial to

evaluate genotype-guided dosing of

warfarin demonstrates, reality is far

more complicated (Gage BF, et al.

JAMA. 2017;318[12]:1115–1124).

Despite GIFT showing that geno-

type-guided dosing prevents more

adverse outcomes than clinically

guided dosing, pharmacogenetic test-

ing to improve warfarin initiation

may not become wide-

spread practice anytime

soon.GIFT was designed to

do what the earlier

COAG and EU-PACT

trials had failed to do:

provide the definitive

answer to the question

of whether genotype-guided warfarin

dosing provided statistically signifi -

cant clinical benefi t to patients under-

going anticoagulant therapy. The in-

consistent results of

POC glucose testing in the critically ill

Lab options, latest studies, one lab’s program Page 10

—continued on 47

Next-gen sequencing

fi nds further clinical

utility in oncologyWilliam Check, PhD

One of the plenary sessions at the

2017 meeting of the Association for

Molecular Pathology—“High Impact

Molecular Diagnostics for Cancer

and Inherited Diseases”—was a vir-

tual mini-course in the latest and

most useful applications of next-

generation sequencing to detect

germline and somatic mutations in

cancer. Both speakers zeroed in on

the clinical utility of their innovative

diagnostic techniques.

A. John Iafrate, MD, PhD, ad-

dressed the expanding use of NGS to

guide targeted therapies in lung can-

cer. Dr. Iafrate, a pathologist at Mas-

sachusetts General Hospital, medical

director of its Center for Integrated

Diagnostics, and a professor at Har-

vard Medical School, focused on

detecting the —continued on 42

—continued on 18

Sara Enders and Steven Cotten, PhD

Dr. James Crawford (right) with (from left) Reeti Khare,

PhD, assistant director of infectious disease diagnostics;

Tarush Kothari, MD, MPH, physician informaticist; and

Yehuda Jacobs, software architect. The question Dr.

Crawford asks his laboratory colleagues is, “Can you

demonstrate that patients are better for having received

care from your lab as opposed to from other labs?”

0118_1-48_SantaFe-MolecDx-Gift_2.indd 1

1/9/18 3:42 PM

Product Guides Detailed charts provide criteria essential to lab directors, administrators, and managers. Product guide listings, an editorial feature, are always free and companies provide the content for their listings, including contact information.

Independent ResearchAD-MARK is a readership and advertising study. Advertise and get a comparative report on your ad and every ad in the issue.

◆◆◆ ReadEx Red Sticker Study examines multiple facets of readers’ attitudes to ads—includes verbatim comments and measures of attention, appeal, and reading.

What others are saying about CAP TODAYAll categories of lab professionals consistently rate CAP TODAY“Most important to my job.”

Ranks No.1 in Readership and Ad Exposures for: (1) pathologists and medical lab directors; (2) clinical laboratory section managers and supervisors; and (3) lab directors, managers, and lab administrators in hospitals with 100+ bedsand independent labs.

Digital and Mobile AccessSee our digital rate card www.captodayonline.com/2019/Advertising/2019_CAPTODAYDigital_RateCard.pdf

2019 CAP TODAY Media Planner2019Issues

BonusDistribution

Instrument/SoftwareProduct Guides What’s inside CAP TODAY: Editorial Planner*

January Texas Society of Pathologists(Austin)

HIMSS (Orlando)

Coagulation analyzers Editorial: 20–25 editorial items, highlighted by in-depth, front-cover features with long story continuations that support back-and-forth reading patterns—readers return to the front cover up to three times.

Interviews with experts from forefront institutions who discuss up-to-the-minute advances (some new, some tried and true) in anatomic, clinical, and molecular pathology and dozens of subspecialties.

Special Laboratory Accreditation Program updates.

Q&A: Covering all lab disciplines, with answers provided by experts. Placed at the back of the magazine, this section is one of the best read.

Newsbytes: Software and technology news—a great spot to showcase IT-related products.

Selected Abstracts: Clinical, anatomic, and molecular abstracts of relevant peer-reviewed papers—editorial that receives extremely high readership scores every month.

Classifi eds: The source for targeting laboratory professionals, products, and services.

Marketplace: An extensive multi-page spread of innovative laboratory products and vendor news.

Put It on the Board: Highlightsof legislative, association, and industry developments presented in concise, easy-to-read news capsules.

Cytopathology and More:A special section featuring what’s new, published three times per year.

Parasitic infection-surgical pathologyTuberculosis-sequencing for

susceptibilityCoagulationCytopathology

February DMT Conference withMike Laposata (Galveston)

USCAP (Washington, DC)

Anatomic pathologycomputer systems

Tumor board—breastCase report—lung adenocarcinomaToxicology

March AACR (Atlanta)

CLMA (Dallas)

Bedside glucosetesting systems

Peripheral blood smear evaluationLung disease

April Executive War College (New Orleans)

Clinical Virology Symposium (Savannah, GA)Pathology Informatics (Pittsburgh)

Molecular testing for STDsLiquid biopsy

May ASCO (Chicago) Next-generation sequencing Bacterial sepsisNext-generation sequencingCytopathology

June ASM (San Francisco)

AACC Preview

Chemistry/Immunoassay analyzers low-volumeand POC

Point-of-care testingMeningitis/encephalitisGenomic testing–clinical vs. consumer

July AACC (Anaheim) Chemistry/Immunoassay ana-lyzers mid- to high-volume

Cutaneous lymphomasDiabetesTest distribution in large systems

August ASCP (Phoenix) Breast pathologySepsis and procalcitoninCytopathology

September NSH (New Orleans)

CAP19 (Orlando)

Pathology Visions (Orlando)

Digital pathologyBilling services and systemsAP core labs

October AABB (San Antonio)

AMP (Baltimore)

Hematology analyzers TransfusionNew tests in hematologyPOC update

November ASC (Salt Lake City)

ASH (Orlando)

Laboratory information systems

HbA1c testing

Flu testing

Update on expert rules

December Urinalysis systems Urinalysis and body fl uidsDiabetes

AD-MARK

AD-MARK

◆◆◆ ReadEx RedSticker Study

AD-MARK

*Five weeks before reservation deadlines, CAP TODAY sales representatives can forecast the more complete and detailed monthly lineup. *EDITORIAL PLANNER SUBJECT TO CHANGE

AD SIZES

Nominal Live Area for Non-Bleed Ads

Bleed Ads*

Trim Bleed

Width Depth Width Depth Width Depth

A Tabloid King 101/8” 127/8” 107/8” 137/8” 111/8” 141/8”

B Tabloid Spread 21” 127/8” 213/4” 137/8” 22” 141/8”

C 5th Col Spread 13” 127/8” 133/8” 137/8” 135/8” 141/8”

D 2/3 Tabloid Square 101/8” 101/4” 107/8” 107/8” 111/8” 111/8”

E 1/2 Tabloid Vertical 43/4” 127/8” 53/8” 137/8” 55/8” 141/8”

F 1/2 Tabloid Horizontal 101/8” 71/8” 107/8” 73/4” 111/8” 8”

G+ 1/3 Tabloid Vertical 3” 127/8” 33/4” 137/8” 4” 141/8”

G 1/4 Tabloid Vertical 21/4” 127/8” 27/8” 137/8” 31/8” 141/8”

H 1/2 Tabloid Horizontal Spread 21” 71/8” 213/4” 73/4” 22” 8”

I Standard “A” Page 71/2” 101/4” 77/8” 107/8” 81/8” 111/8”

J Standard “A” Spread 15” 101/4” 15” 107/8” 151/4” 111/8”

K 2/3 Standard Island 43/4” 101/4” 53/8” 107/8” 55/8” 111/8”

L 1/2 Standard Vertical 31/2” 101/4” 4” 107/8” 41/4” 111/8”

M 1/2 Standard Island 43/4” 81/2” 53/8” 91/8” 55/8” 91/4”

N 1/2 Standard Horizontal 73/8” 51/2” 77/8” 6” 81/8” 61/4”

O 1/3 Standard Vertical 21/4” 101/4” 27/8” 107/8” 31/8” 111/8”

P 1/3 Standard Square 43/4” 43/4” 53/8” 53/8” 55/8” 55/8”

Q 1/4 Standard Island 31/2” 5” 4” 55/8” 41/4” 57/8”

R 1/4 Standard Horizontal 73/8” 21/2” 77/8” 31/8” 81/8” 31/4”

S 1/4 Standard Vertical 21/4” 81/2” 27/8” 91/8” 31/8” 91/4”

T 2/3 Standard Banner 101/8” 43/4” 107/8” 51/4” 111/8” 51/2”

U 1/2 Standard Banner 101/8” 33/4” 107/8” 41/4” 111/8” 41/2”

V 1/3 Standard Banner 101/8” 23/4” 107/8” 31/4” 111/8” 31/2”

W 1/4 Standard Banner 101/8” 17/8” 107/8” 21/2” 111/8” 23/4”

*Crop and register marks offset should be set 1/4” beyond trim. Live type is recommended to maintain at least 1/4” space inside trimming edges.

2019 CAP TODAY Mechanical RequirementsIf you have questions about file production or transfer, please contact Keith Eilers at 847-832-7528 or e-mail keilers@cap.orgClosing dates: Insertion Orders: 4th of month preceding issue date. Materials: 14th of month preceding issue date.

A CBD

E

F

G

HI J K L

M N

O

QP RS

WVUT

G+